Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

US and Korea grants patents for VAL001

US Patent and Trademark Office (USPTO) and Korean Intellectual Property Office (KIPO) has announced the intent to grant Respiratorius patent for VAL001, "A Pharmaceutical Composition Comprising a HDAC inhibitor and a steroid and the use thereof."After the formal fees have been paid, the patent will be granted, which will give Respiratorius market exclusivity in the United States and Korea until 2031. Previously the patent has been granted in Europe and Japan under equivalent conditions. The patent applies to a combination of a HDAC inhibitor and a steroid for pretreatment before

SKF exhibits at Global Wind Summit to exchange wind energy knowledge and showcase its latest products

At the world’s largest wind energy event, SKF will exhibit its spherical-roller bearings for wind turbine main shafts as well as other solutions for the wind energy industry.Gothenburg, Sweden, 8 August 2018: As an active member of WindEurope, SKF will play a key role in the Global Wind Summit where the company will exchange industry knowledge via presentations and on its exhibition stand. The Global Wind Summit is a combination of the WindEnergy Exhibition and WindEurope Conference and takes place in Hamburg, Germany between the 25th and 28th September.  SKF is proud to showcase its

Saab Receives Order for Self-Protection Systems for India’s Dhruv Helicopter

Saab has received a follow-on order from Hindustan Aeronautics Limited (HAL) for the IDAS-2 self-protection suite for the Indian Army’s Dhruv helicopter. The order amounts to approximately MSEK 350.The order includes the IDAS-2 (Integrated Defensive Aids Suite) and the production will take place at Saab’s facility in Centurion, South Africa. Deliveries will begin during 2019. “This follow-on order confirms our successful partnership with HAL and further establishes Saab as a local partner to the Indian industry,” says Anders Carp, head of Saab business area Surveillance. IDAS is

Stora Enso signs a credit rating agreement with Fitch Ratings

STORA ENSO OYJ INVESTOR NEWS 8 August 2018 at 11.00 EESTStora Enso has signed a new credit rating agreement with Fitch Ratings. Fitch Ratings has assigned Stora Enso Oyj a rating of BBB- with a stable outlook. Stora Enso has also terminated its credit rating agreement with the rating agency S&P Global Ratings (Standard & Poor’s) and asked S&P to withdraw their rating, which currently is BB+ with stable outlook. The credit rating of Stora Enso Oyj will from now on be assessed by Fitch Ratings and Moody’s Investors Service. Moody’s current rating for Stora Enso Oyj is Ba1 with positive

The production for July 2018 totaled in 24.1 GWh

The production from the Company’s wind farms for July 2018 totaled 24.1 GWh, of which 16.7 GWh were from own and 7.4 GWh from co-owned parks. Production is about 30 percent below expectation. The availability has been around 97 percent.Rabbalshede Kraft offer operating services and operates wind farms around Sweden, in-house or for external partners. Rabbalshede Kraft operates 186 turbines (450 MW), of which 101 turbines (272 MW) are own or co-owned and 85 turbines (178 MW) are owned by external partners. The annual production capacity of the 186 wind turbines is 1 243 GWh. For

Conference call regarding Elekta’s Q1 report for 2018/19

STOCKHOLM, August 8, 2018 – Elekta (EKTA-B.ST) will publish its Q1 report for 2018/19 on August 30, as per: · The report will be published at 07:30 CET. · Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO. To take part in the conference call, please dial in about five minutes in advance. · UK dial-in number: +44 (0) 203 008 9806 · US dial-in number: +1 855 831 5945 · Swedish dial-in number: +46 (0) 8 506 395 49 The telephone conference will also be broadcasted live online, through the

Vivacom launches 4G Voice service and Wi-Fi calling in Bulgaria

· The biggest telecom in total revenues on the Bulgarian market, VIVACOM, and Ericsson will deploy 4G Voice service (Voice over LTE) and Wi-Fi calling services in Bulgaria · Vivacom’s customers will benefit from high-definition voice servicesVivacom is extending its contract with Ericsson (NASDAQ:ERIC) to deploy 4G Voice service and Wi-Fi calling . With the pre-integrated Fast VoLTE Launch solution, the service’s deployment time has been significantly reduced. The

Revenio Group Corporation: Managers' transactions

Revenio Group Corporation, Managers' transactions, August 8, 2018 at 10:00 Revenio Group Corporation: Managers' transactions Revenio Group Oyj  - Managers' Transactions____________________________________________Person subject to the notification requirementName: Hildén TimoPosition: Chief Executive Officer(X) Legal personIssuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20180808093336_2____________________________________________Transaction date: 2018-08-06Venue: FIRST NORTH FINLAND

Outotec to deliver minerals processing technology to South America

OUTOTEC OYJ  PRESS RELEASE  AUGUST 8, 2018   AT 10:00 AMOutotec to deliver minerals processing technology to South America Outotec has been awarded an order for the delivery of minerals processing technology to a new copper concentrator to be built in South America. The contract value booked in Outotec's 2018 third quarter order intake is approximately EUR 25 million. Outotec's scope includes engineering and the delivery of flotation cells and filters. The deliveries will take place by the end of 2019. "We are pleased to be part of one of the most important mining projects in

Eurocine Vaccines´ nasal influenza vaccine candidate Immunose™ FLU showed good safety in older adults

Eurocine Vaccines today announced good safety and tolerability in older adults, in the second clinical phase I/II study including their quadrivalent influenza vaccine candidate. Immunose™ FLU is a novel nose drop formulation based on the company´s technology Endocine™ and inactivated split influenza antigens.- I am very happy that we have once again confirmed good safety, this time in older adults, a population in need of better influenza vaccines. Now we look forward to the immunological results, which are expected in October, says Dr. Anna-Karin Maltais, CSO, Vice President R&D. The

#18-1397 Recalculation of reference value for certain instruments with Tesla Motors Inc. as underlying security

The reference value for certain certificates with Tesla Motors Inc. as underlying has been recalculated in accordance with the instruments final terms. This applies to the following instruments: Symbol: BEAR TESLA X10 VON2 Symbol: BEAR TSLA X10 V2 Symbol: BEAR TESLA X10 VON Symbol: BEAR TSLA X10 V Symbol: BEAR TESLA X8 VONThe instruments will be traded under observation for the duration of this trading day. For more information concerning the recalculation, please contact the issuer of the affected instrument. For further information concerning this NGM notice please

Presentation of Probi’s Q2 report 2018

Probi’s report for the second quarter 2018 will be published on Monday, 13 August at 8.00 a.m. CET. In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com  or https://tv.streamfabriken.com/probi-q2-2018 The presentation can also be followed via a telephone conference on the following telephone number: Sweden: +46 8 56 64 26 64 UK: +44 20 30

EVRY strengthens its focus on health technology across the Nordic region

EVRY is acquiring Exonor, a leading provider of strategic consultancy and support services in relation to implementing clinical IT systems. This acquisition will strengthen EVRY’s expertise in what is an operationally critical area for Nordic health trusts.Over the coming years, the health sector will be investing significantly in modernising its core technology systems and making greater use of industry-standard systems in order to improve patient care and simplify collaboration within and between individual health trusts. Critical success factors for achieving these aims include

Emma Levén becomes the new group CFO at FundedByMe

Emma Levén, previously CFO at Swedeltaco AB, now becomes a part of the team behind the biggest and fastest growing crowdfunding platform in Scandinavia. She has a background in international growth and listings, and will be a strong addition as Group Chief Financial Officer at FundedByMe prior to upcoming listing at NGM as well as future ventures.— It is with great anticipation I look forward to working with FundedByMe and seeing them become a stronger and more global company. It is a company that has gone through an impressive journey through the years and I see it as a great opportunity.

The European Patent Office intend to grant Brighter’s patent for AI-powered monitoring of medical devices.

The European Patent Office intend to grant Brighter’s European patent application 16744322.5 regarding Artificial Intelligence-driven medical device monitoring functionality. The patent secures rights to unique functionalities in The Benefit Loop to secure operations of medical devices. It also adds valuable functionalities to Actiste, Brighter’s unique diabetes management service, currently being introduced to the market in the United Arab Emirates, Indonesia, Thailand and Sweden. – Over the years, Brighter has built an strong IP portfolio, and we are continuously strengthening it

Invitation to THQ Nordic’s Q2 presentation

THQ Nordic hereby invites you to a presentation in connection with the publishing of the interim report for the second quarter of 2018. The report will be published the same morning, well before the market opens.The presentation will be held in English by CEO Lars Wingefors and afterwards you will be invited to ask questions. The event will last approximately one hour. Date: August 15, 2018.Time: 09:00 (CET)Place: Carnegie Hall, Regeringsgatan 56, Stockholm. Please register in advance for physical presence or telephone conference participation: https://financialhearings.com/event/

New head of Consultancy Services business area

Effective August 9, 2018, Mikael Karlsson has been appointed Business Area President of Consultancy Services. Mikael has extensive experience of international business and a long background in Studsvik in several leading positions. At present he is a business developer responsible for development of new services. He succeeds Stefan Bergström who is leaving the company following a mutual agreement. Mikael Karlsson will also be a member of Studsvik's Executive Group Management. For more information, please contact: Camilla Hoflund, +46 760 02 10 66 Facts about Studsvik Studsvik

Viking Line first to launch Benefit Cosmetics in Finland and onboard a passenger vessel in Europe

Benefit Cosmetics is a global cosmetic brand, based in San Francisco in United States of America. Founded in the year 1976, by twins Jean and Jane Ford, as a beauty boutique, they initially specialized in offering quick-fix beauty products for customers. Viking Line is now introducing this reputed and iconic brand on all their seven vessels.-       We are very happy to be the first to launch Benefit Cosmetics in Finland and on the Baltic Sea onboard all our cruise ships.  We’re also proud to offer their brow bar services onboard Viking Grace. Benefit Cosmetics is a unique beauty and

Photocure ASA: Results for the second quarter of 2018

Oslo, Norway, 8 August 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 56% in local currency for the U.S. market in the second quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 42.4 million (Q2 2017: NOK 37.6) and a recurring EBITDA of NOK 0.7 million (NOK -4.4  million). The company reiterates the positive outlook for the U.S. market with the reimbursement of Blue Light Cystoscopy (BLC(TM)) with Cysview, FDA approval of label expansion for Cysview and the launch of Cysview in combination with flexible cystoscopes in the surveillance of bladder cancer

Etrion Releases Second Quarter 2018 Results

August 8, 2018, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2018.  Etrion Corporation delivered strong project-level results in the second quarter of 2018 from its Japanese assets. Higher installed capacity and electricity production, combined with significant reduction in corporate overhead resulted in a significant increase in

Interim report for 2nd quarter 2018

Financial report for the period ended 30th June 2018 Key Facts for Quarter 2 2018 (1st April 2018 – 30th June 2018) Q2 2018 all-time high in customer deposits All figures are compared to the same quarter last year if not explicitly stated otherwise ·  Revenues increased by 39.36% to €3,837,061 (€2,753,290). ·  EBIT increased by 60.58% to €1,378,538 (€858,470). ·  EBIT margin of 35.92% (31.18%).  ·  All-time high in customer deposits with an increase of 49.53% to €6,940,630 (€4,641,568).   ·  29,402 new registered customers (23,177), increase of 26.86%.  ·

Electrolux divests BEAM and Sanitaire in North America

Electrolux announced today it has divested its U.S.-based commercial and central vacuum cleaner businesses in North America, including the brands Sanitaire and BEAM. The decision is in line with the strategy of the business area Home Care & SDA to focus on global brands and product categories.Electrolux has divested the commercial business, which provides professional customers in North America with a wide range of vacuum cleaners under the Sanitaire brand, to BISSELL Inc. The global central vacuum cleaner business based in North America, which provides products under the BEAM brand, is

Interim report for Q2 2018

The second quarter of 2018 was eventful and financially strong, both revenue and profitability wise. Sales increased by more than 40 percent, driven by more than a doubling in sales of our own product portfolio. We also signed a combined distribution and licensing agreement for China that contributed new licensing revenues. We generated an EBITDA of SEK 9.1 million, which is more than a doubling compared to the previous year, and a margin of 17 percent. This despite the cost of over SEK 11 million for cancelling our previous distribution agreement in China. Net profit for the period is

There are no items matching the current filter
There are no more items matching the current filter
Back to top